{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:50:18Z","timestamp":1753890618648,"version":"3.41.2"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioinform."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>T-cell suppression in patients with Acute myeloid leukemia (AML) limits tumor cell clearance. This study aimed to explore the role of T-cell senescence-related genes in AML progression using single-cell RNA sequencing (scRNA-seq), bulk RNA sequencing (RNA-seq), and survival data of patients with AML in the TCGA database.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The Uniform Manifold Approximation and Projection (UMAP) algorithm was used to identify different cell clusters in the GSE116256, and differentially expressed genes (DEGs) in T-cells were identified using the FindAllMarkers analysis. GSE114868 was used to identify DEGs in AML and control samples. Both were crossed with the CellAge database to identify aging-related genes. Univariate and multivariate regression analyses were performed to screen prognostic genes using the AML Cohort in The Cancer Genome Atlas (TCGA) Database (TCGA-LAML), and risk models were constructed to identify high-risk and low-risk patients. Line graphs showing the survival of patients with AML were created based on the independent prognostic factors, and Receiver Operating Characteristic Curve (ROC) curves were used to calculate the predictive accuracy of the line graph. GSE71014 was used to validate the prognostic ability of the risk score model. Tumor immune infiltration analysis was used to compare differences in tumor immune microenvironments between high- and low-risk AML groups. Finally, the expression levels of prognostic genes were verified using polymerase chain reaction (RT-qPCR).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>31 AMLDEGs associated with aging identified 4 prognostic genes (CALR, CDK6, HOXA9, and PARP1) by univariate, multivariate, and stepwise regression analyses with risk modeling The ROC curves suggested that the line graph based on the independent prognostic factors accurately predicted the 1-, 3-, and 5-year survival of patients with AML. Tumor immune infiltration analyses suggested significant differences in the tumor immune microenvironment between low- and high-risk groups. Prognostic genes showed strong binding activity to target drugs (IGF1R and ABT737). RT-qPCR verified that prognostic gene expression was consistent with the data prediction results.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>CALR, CDK6, HOXA9, and PARP1 predicted disease progression and prognosis in patients with AML. Based on these, we developed and validated a new AML risk model with great potential for predicting patients\u2019 prognosis and survival.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fbinf.2025.1606284","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T05:26:33Z","timestamp":1750829193000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated single-cell and bulk RNA dequencing to identify and validate prognostic genes related to T Cell senescence in acute myeloid leukemia"],"prefix":"10.3389","volume":"5","author":[{"given":"Mengyao","family":"Sha","sequence":"first","affiliation":[]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[]},{"given":"Haifeng","family":"Hou","sequence":"additional","affiliation":[]},{"given":"Huaihui","family":"Dou","sequence":"additional","affiliation":[]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5132","DOI":"10.1182\/bloodadvances.2022007334","article-title":"Pevonedistat plus azacitidine vs azacitidine alone in higher-risk MDS\/chronic myelomonocytic leukemia or low-blast-percentage AML","volume":"6","author":"Ad\u00e8s","year":"2022","journal-title":"Blood Adv."},{"key":"B2","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","article-title":"Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage","volume":"20","author":"Aran","year":"2019","journal-title":"Nat. Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13059-020-01990-9","article-title":"A multidimensional systems biology analysis of cellular senescence in aging and disease","volume":"21","author":"Avelar","year":"2020","journal-title":"Genome Biol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e140179","DOI":"10.1172\/jci.insight.140179","article-title":"Risk-associated alterations in marrow T cells in pediatric leukemia","volume":"5","author":"Bailur","year":"2020","journal-title":"JCI Insight"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1002\/cncr.35028","article-title":"Top advances of the year: myeloproliferative neoplasms","volume":"129","author":"Bhave","year":"2023","journal-title":"Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e13041","DOI":"10.1111\/acel.13041","article-title":"A human tissue-specific transcriptomic analysis reveals a complex relationship between aging, cancer, and cellular senescence","volume":"18","author":"Chatsirisupachai","year":"2019","journal-title":"Aging Cell"},{"key":"B8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1471-2105-12-35","article-title":"VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R","volume":"12","author":"Chen","year":"2011","journal-title":"BMC Bioinforma."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.7150\/ijms.96627","article-title":"Analysis of prognostic biomarker models of TXNIP\/NLRP3\/IL1B inflammasome pathway in patients with acute myeloid leukemia","volume":"21","author":"Chen","year":"2024","journal-title":"Int. J. Med. Sci."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.14336\/ad.2025.0061","article-title":"Targeting T-cell aging to remodel the aging immune system and revitalize geriatric immunotherapy","author":"Chen","year":"2025","journal-title":"Aging Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/moh.0000000000000245","article-title":"Deregulation of the HOXA9\/MEIS1 axis in acute leukemia","volume":"23","author":"Collins","year":"","journal-title":"Curr. Opin. Hematol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/onc.2015.174","article-title":"Role of HOXA9 in leukemia: dysregulation, cofactors and essential targets","volume":"35","author":"Collins","year":"","journal-title":"Oncogene"},{"key":"B13","doi-asserted-by":"publisher","first-page":"6385","DOI":"10.3390\/cancers13246385","article-title":"PARP inhibitors and myeloid neoplasms: a double-edged sword","volume":"13","author":"Csizmar","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1182\/blood.2022019244","article-title":"Silencing with SAFB: a new role for HOXA9 in AML","volume":"141","author":"Deshpande","year":"2023","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/nature11005","article-title":"Systematic identification of genomic markers of drug sensitivity in cancer cells","volume":"483","author":"Garnett","year":"2012","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e107468","DOI":"10.1371\/journal.pone.0107468","article-title":"pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels","volume":"9","author":"Geeleher","year":"2014","journal-title":"PLoS One"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1093\/bioinformatics\/btab806","article-title":"Make interactive complex heatmaps in R","volume":"38","author":"Gu","year":"2022","journal-title":"Bioinformatics"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3844","DOI":"10.1093\/bioinformatics\/btac409","article-title":"ggtranscript: an R package for the visualization and interpretation of transcript isoforms using ggplot2","volume":"38","author":"Gustavsson","year":"2022","journal-title":"Bioinformatics"},{"key":"B19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinforma."},{"key":"B20","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.0006-341x.2000.00337.x","article-title":"Time-dependent ROC curves for censored survival data and a diagnostic marker","volume":"56","author":"Heagerty","year":"2000","journal-title":"Biometrics"},{"key":"B21","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41586-024-08439-0","article-title":"Immune evasion through mitochondrial transfer in the tumour microenvironment","volume":"638","author":"Ikeda","year":"2025","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","first-page":"4794","DOI":"10.1182\/bloodadvances.2021004638","article-title":"PARP1 as a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome","volume":"5","author":"Kontandreopoulou","year":"2021","journal-title":"Blood Adv."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s13205-021-03038-6","article-title":"Pleiotropic role of PARP1: an overview","volume":"12","author":"Kumar","year":"2022","journal-title":"3 Biotech."},{"key":"B24","doi-asserted-by":"publisher","first-page":"5021","DOI":"10.1111\/jcmm.15122","article-title":"Hsa_circ_0079662 induces the resistance mechanism of the chemotherapy drug oxaliplatin through the TNF-\u03b1 pathway in human colon cancer","volume":"24","author":"Lai","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/jso.27358","article-title":"Clinicopathological characteristics of pheochromocytoma\/paraganglioma and screening of prognostic markers","volume":"128","author":"Lei","year":"2023","journal-title":"J. Surg. Oncol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3023127","DOI":"10.1155\/2020\/3023127","article-title":"Potential molecular mechanisms of plantain in the treatment of gout and hyperuricemia based on network pharmacology","volume":"2020","author":"Liu","year":"2020","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e2109144118","DOI":"10.1073\/pnas.2109144118","article-title":"HIF-1-regulated expression of calreticulin promotes breast tumorigenesis and progression through Wnt\/\u03b2-catenin pathway activation","volume":"118","author":"Liu","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.3324\/haematol.2023.283647","article-title":"Targeting TNF\/IL-17\/MAPK pathway in hE2A-PBX1 leukemia: effects of OUL35, KJ-Pyr-9, and CID44216842","volume":"109","author":"Luo","year":"2024","journal-title":"Haematologica"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1182\/blood.2023021680","article-title":"CD8+ T-cell differentiation and dysfunction inform treatment response in acute myeloid leukemia","volume":"144","author":"Mazziotta","year":"2024","journal-title":"Blood"},{"key":"B30","doi-asserted-by":"publisher","first-page":"19811","DOI":"10.1038\/s41598-024-65345-1","article-title":"Establishment and verification of a TME prognosis scoring model based on the acute myeloid leukemia single-cell transcriptome","volume":"14","author":"Miao","year":"2024","journal-title":"Sci. Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.3324\/haematol.2024.285014","article-title":"A phase I study of pevonedistat, azacitidine, and venetoclax in patients with relapsed\/refractory acute myeloid leukemia","volume":"109","author":"Murthy","year":"2024","journal-title":"Haematologica"},{"key":"B32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ijlh.13135","article-title":"How I investigate acute myeloid leukemia","volume":"42","author":"Narayanan","year":"2020","journal-title":"Int. J. Lab. Hematol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1002\/ijc.33054","article-title":"The role of CDK6 in cancer","volume":"147","author":"Nebenfuehr","year":"2020","journal-title":"Int. J. Cancer"},{"key":"B34","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41586-019-1410-1","article-title":"Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion","volume":"572","author":"Paczulla","year":"2019","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","first-page":"16","DOI":"10.6004\/jnccn.2021.0002","article-title":"NCCN guidelines insights: acute myeloid leukemia, version 2.2021","volume":"19","author":"Pollyea","year":"2021","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.scog.2017.10.001","article-title":"Model selection and prediction of outcomes in recent onset schizophrenia patients who undergo cognitive training","volume":"11","author":"Ramsay","year":"2018","journal-title":"Schizophr. Res. Cogn."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41556-022-00842-x","article-title":"Telomere dysfunction in ageing and age-related diseases","volume":"24","author":"Rossiello","year":"2022","journal-title":"Nat. Cell Biol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1093\/nar\/gku631","article-title":"The multiMiR R package and database: integration of microRNA-target interactions along with their disease and drug associations","volume":"42","author":"Ru","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2","DOI":"10.18637\/jss.v079.c02","article-title":"plotROC: a tool for plotting ROC curves","volume":"79","author":"Sachs","year":"2017","journal-title":"J. Stat. Softw."},{"key":"B41","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ccell.2020.05.014","article-title":"Targeting RSPO3-LGR4 signaling for leukemia stem cell eradication in acute myeloid leukemia","volume":"38","author":"Salik","year":"2020","journal-title":"Cancer Cell"},{"key":"B42","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1182\/blood.2019003267","article-title":"CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemia","volume":"136","author":"Schmoellerl","year":"2020","journal-title":"Blood"},{"key":"B43","doi-asserted-by":"publisher","first-page":"638010","DOI":"10.3389\/fimmu.2021.638010","article-title":"Markers of T Cell exhaustion and senescence and their relationship to plasma TGF-\u03b2 levels in treated HIV+ immune non-responders","volume":"12","author":"Shive","year":"2021","journal-title":"Front. Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13045-023-01476-8","article-title":"A phase 1\/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethy lating agents","volume":"16","author":"Short","year":"2023","journal-title":"J. Hematol. and Oncol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s12672-024-01150-6","article-title":"MICAL1 promotes the proliferation in acute myeloid leukemia and is associated with clinical prognosis and immune infiltration","volume":"15","author":"Song","year":"2024","journal-title":"Discov. Oncol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"4706","DOI":"10.1038\/s41467-019-12464-3","article-title":"Single-cell transcriptomics of human T cells reveals tissue and activation signatures in health and disease","volume":"10","author":"Szabo","year":"2019","journal-title":"Nat. Commun."},{"key":"B47","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s00262-023-03594-1","article-title":"Bone marrow-derived mesenchymal stromal cells obstruct AML-targeting CD8(+) clonal effector and CAR T-cell function while promoting a senescence-associated phenotype","volume":"73","author":"Towers","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1093\/bioinformatics\/btv300","article-title":"GOplot: an R package for visually combining expression data with functional analysis","volume":"31","author":"Walter","year":"2015","journal-title":"Bioinformatics"},{"key":"B49","doi-asserted-by":"publisher","first-page":"989286","DOI":"10.3389\/fimmu.2022.989286","article-title":"Cuproptosis related genes associated with Jab1 shapes tumor microenvironment and pharmacological profile in nasopharyngeal carcinoma","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"7798","DOI":"10.3390\/ijms25147798","article-title":"In vivo chemical screening in zebrafish embryos identified FDA-approved drugs that induce differentiation of acute myeloid leukemia cells","volume":"25","author":"Wei","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"eadf8522","DOI":"10.1126\/sciadv.adf8522","article-title":"M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolism","volume":"9","author":"Weinh\u00e4user","year":"2023","journal-title":"Sci. Adv."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1281141","DOI":"10.3389\/fmolb.2023.1281141","article-title":"A prognostic model based on prognosis-related ferroptosis genes for patients with acute myeloid leukemia","volume":"10","author":"Wu","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s11011-022-01099-x","article-title":"Propofol inhibits glioma progression by regulating circMAPK4\/miR-622\/HOXA9 axis","volume":"38","author":"Xiao","year":"2023","journal-title":"Metab. Brain Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.3390\/biomedicines11102847","article-title":"Immunological phenotyping of mice with a point mutation in Cdk4","volume":"11","author":"Yabas","year":"2023","journal-title":"Biomedicines"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s40265-019-01163-4","article-title":"Targeting BCL2 in chronic lymphocytic leukemia and other hematologic malignancies","volume":"79","author":"Yalniz","year":"2019","journal-title":"Drugs"},{"key":"B56","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"Omics"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.2147\/ijwh.s334756","article-title":"An aging-related gene signature-based model for risk stratification and prognosis prediction in breast cancer","volume":"13","author":"Yuan","year":"2021","journal-title":"Int. J. Womens Health"},{"key":"B58","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/1471-2105-14-244","article-title":"RCircos: an R package for Circos 2D track plots","volume":"14","author":"Zhang","year":"2013","journal-title":"BMC Bioinforma."},{"key":"B59","doi-asserted-by":"publisher","first-page":"661939","DOI":"10.3389\/fimmu.2021.661939","article-title":"NLRP3 inflammasome promotes the progression of acute myeloid leukemia via IL-1\u03b2 pathway","volume":"12","author":"Zhong","year":"2021","journal-title":"Front. Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s41065-024-00338-8","article-title":"Glutamine metabolism-related genes predict the prognostic risk of acute myeloid leukemia and stratify patients by subtype analysis","volume":"161","author":"Zhou","year":"2024","journal-title":"Hereditas"}],"container-title":["Frontiers in Bioinformatics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbinf.2025.1606284\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T05:26:36Z","timestamp":1750829196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbinf.2025.1606284\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":60,"alternative-id":["10.3389\/fbinf.2025.1606284"],"URL":"https:\/\/doi.org\/10.3389\/fbinf.2025.1606284","relation":{},"ISSN":["2673-7647"],"issn-type":[{"type":"electronic","value":"2673-7647"}],"subject":[],"published":{"date-parts":[[2025,6,25]]},"article-number":"1606284"}}